Health your username February 11, 2021 On Feb. 4, the Instituto Mexicano del Seguro Social (IMSS) filed a notice to appeal a Jan. 5 decision by Judge Damon R. Leichty of the Northern District of Indiana that ruled to dismiss a case against Zimmer Biomet Holdings alleging that it paid bribes to push Mexican government officials to facilitate the movement of Zimmer Biomet medical device products into Mexico. The case will now be heard before the Seventh Circuit. In its complaint, IMSS claimed that Zimmer Biomet officials, through subsidiary Biomet 3i, traveled to Mexico to act “as bagmen for passing on bribes to Mexican government officials” so that they would allow the import of Zimmer Biomet’s unregistered medical devices. The plaintiff padded its argument with Zimmer Biomet’s history of operating bribery schemes, namely in 2017 when the company settled for more than $30 million with the U.S. Department of Justice and the Securities and Exchange Commission to resolve investigations that found it was using a third-party broker to bribe Mexican officials for importing unregistered dental products.